BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rice TW, Zuccaro G, Adelstein DJ, Rybicki LA, Blackstone EH, Goldblum JR. Esophageal Carcinoma: Depth of Tumor Invasion Is Predictive of Regional Lymph Node Status. The Annals of Thoracic Surgery 1998;65:787-92. [DOI: 10.1016/s0003-4975(97)01387-8] [Cited by in Crossref: 269] [Cited by in F6Publishing: 76] [Article Influence: 11.2] [Reference Citation Analysis]
Number Citing Articles
1 Li X, Galipeau PC, Paulson TG, Sanchez CA, Arnaudo J, Liu K, Sather CL, Kostadinov RL, Odze RD, Kuhner MK. Temporal and spatial evolution of somatic chromosomal alterations: a case-cohort study of Barrett's esophagus. Cancer Prev Res (Phila). 2014;7:114-127. [PMID: 24253313 DOI: 10.1158/1940-6207.CAPR-13-0289] [Cited by in Crossref: 107] [Cited by in F6Publishing: 65] [Article Influence: 11.9] [Reference Citation Analysis]
2 Feczko AF, Louie BE. Endoscopic Resection in the Esophagus. Thorac Surg Clin 2018;28:481-97. [PMID: 30268294 DOI: 10.1016/j.thorsurg.2018.07.006] [Reference Citation Analysis]
3 Sgourakis G, Gockel I, Lang H. Endoscopic and surgical resection of T1a/T1b esophageal neoplasms: A systematic review. World J Gastroenterol 2013; 19(9): 1424-1437 [PMID: 23539431 DOI: 10.3748/wjg.v19.i9.1424] [Cited by in CrossRef: 84] [Cited by in F6Publishing: 70] [Article Influence: 9.3] [Reference Citation Analysis]
4 Wu LF, Wang BZ, Feng JL, Cheng WR, Liu GR, Xu XH, Zheng ZC. Preoperative TN staging of esophageal cancer: Comparison of miniprobe ultrasonography, spiral CT and MRI. World J Gastroenterol 2003; 9(2): 219-224 [PMID: 12532435 DOI: 10.3748/wjg.v9.i2.219] [Cited by in CrossRef: 63] [Cited by in F6Publishing: 45] [Article Influence: 3.3] [Reference Citation Analysis]
5 Deng J, Chu X, Ren Z, Wang B. Relationship between T stage and survival in distantly metastatic esophageal cancer: A STROBE-compliant study. Medicine (Baltimore) 2020;99:e20064. [PMID: 32384472 DOI: 10.1097/MD.0000000000020064] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Rayner-Hartley E, Takach O, Galorport C, Enns RA. Diagnosis and Management of Barrett's Esophagus: A Retrospective Study Comparing the Endoscopic Assessment of Early Esophageal Lesions in the Community versus a Specialized Center. Can J Gastroenterol Hepatol 2016;2016:5749573. [PMID: 27446850 DOI: 10.1155/2016/5749573] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
7 di Pietro M, Alzoubaidi D, Fitzgerald RC. Barrett's esophagus and cancer risk: how research advances can impact clinical practice. Gut Liver 2014;8:356-70. [PMID: 25071900 DOI: 10.5009/gnl.2014.8.4.356] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
8 Manner H, Pech O, Heldmann Y, May A, Pauthner M, Lorenz D, Fisseler-Eckhoff A, Stolte M, Vieth M, Ell C. The frequency of lymph node metastasis in early-stage adenocarcinoma of the esophagus with incipient submucosal invasion (pT1b sm1) depending on histological risk patterns. Surg Endosc. 2015;29:1888-1896. [PMID: 25294553 DOI: 10.1007/s00464-014-3881-3] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 6.8] [Reference Citation Analysis]
9 Tan C, Qian X, Guan Z, Yang B, Ge Y, Wang F, Cai J. Potential biomarkers for esophageal cancer. Springerplus. 2016;5:467. [PMID: 27119071 DOI: 10.1186/s40064-016-2119-3] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 5.7] [Reference Citation Analysis]
10 Chen P, Zheng Y, He H, Wang PY, Wang F, Liu SY. The role of endoscopic tumor length in resected esophageal squamous cell carcinoma: a retrospective study. J Thorac Dis 2021;13:353-61. [PMID: 33569215 DOI: 10.21037/jtd-21-108] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Wang G, Wu A, Cheng X, Ji J. Risk factors associated with early recurrence of adenocarcinoma of gastroesophageal junction after curative resection. Chin J Cancer Res 2013;25:334-8. [PMID: 23825910 DOI: 10.3978/j.issn.1000-9604.2013.06.11] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
12 Graham D, Sever N, Magee C, Waddingham W, Banks M, Sweis R, Al-Yousuf H, Mitchison M, Alzoubaidi D, Rodriguez-Justo M, Lovat L, Novelli M, Jansen M, Haidry R. Risk of lymph node metastases in patients with T1b oesophageal adenocarcinoma: A retrospective single centre experience. World J Gastroenterol 2018; 24(41): 4698-4707 [PMID: 30416317 DOI: 10.3748/wjg.v24.i41.4698] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
13 Zhang P, Xi M, Zhao L, Li QQ, He LR, Liu SL, Shen JX, Liu MZ. Efficacy and prognostic analysis of chemoradiotherapy in patients with thoracic esophageal squamous carcinoma with cervical lymph nodal metastasis alone. Radiat Oncol 2014;9:256. [PMID: 25424871 DOI: 10.1186/s13014-014-0256-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
14 Kahn A, Kamboj AK, Muppa P, Sawas T, Lutzke LS, Buras MR, Golafshar MA, Katzka DA, Iyer PG, Smyrk TC, Wang KK, Leggett CL. Staging of T1 esophageal adenocarcinoma with volumetric laser endomicroscopy: a feasibility study.Endosc Int Open. 2019;7:E462-E470. [PMID: 30931378 DOI: 10.1055/a-0838-5326] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Mukherjee K, Chakravarthy AB, Goff LW, El-Rifai W. Esophageal adenocarcinoma: treatment modalities in the era of targeted therapy. Dig Dis Sci 2010;55:3304-14. [PMID: 20300841 DOI: 10.1007/s10620-010-1187-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
16 Feith M, Stein HJ, Siewert JR. Pattern of lymphatic spread of Barrett's cancer. World J Surg. 2003;27:1052-1057. [PMID: 12917758 DOI: 10.1007/s00268-003-7060-2] [Cited by in Crossref: 97] [Cited by in F6Publishing: 86] [Article Influence: 5.1] [Reference Citation Analysis]
17 Li M, Zhang X, Zhao F, Luo Y, Kong L, Yu J. Involved-field radiotherapy for esophageal squamous cell carcinoma: theory and practice. Radiat Oncol 2016;11:18. [PMID: 26846932 DOI: 10.1186/s13014-016-0589-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
18 Kneist W, Schreckenberger M, Bartenstein P, Grünwald F, Oberholzer K, Junginger T. [Positron emission tomography for preoperative lymph node diagnosis in esophageal carcinoma]. Chirurg 2003;74:922-30; discussion 929-30. [PMID: 14605734 DOI: 10.1007/s00104-003-0711-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
19 Konda VJ, Ferguson MK. Esophageal resection for high-grade dysplasia and intramucosal carcinoma: When and how? World J Gastroenterol 2010; 16(30): 3786-3792 [PMID: 20698041 DOI: 10.3748/wjg.v16.i30.3786] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
20 Cho JW. The Role of Endosonography in the Staging of Gastrointestinal Cancers. Clin Endosc. 2015;48:297-301. [PMID: 26240802 DOI: 10.5946/ce.2015.48.4.297] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
21 Tian D, Huang H, Yang YS, Jiang KY, He X, Guo XG, Chen LQ. Depth of Invasion into the Circular and Longitudinal Muscle Layers in T2 Esophageal Squamous Cell Carcinoma Does Not Affect Prognosis or Lymph Node Metastasis: A Multicenter Retrospective Study. World J Surg 2020;44:171-8. [PMID: 31552458 DOI: 10.1007/s00268-019-05194-6] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Tang S, Gao L, Bi Q, Xu G, Wang S, Zhao G, Chen Z, Zheng X, Pan Y, Zhao L, Kang J, Yang G, Shi Y, Wu K, Gong T, Fan D. SDR9C7 promotes lymph node metastases in patients with esophageal squamous cell carcinoma. PLoS One 2013;8:e52184. [PMID: 23341893 DOI: 10.1371/journal.pone.0052184] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
23 Mizutani M, Murakami G, Nawata S, Hitrai I, Kimura W. Anatomy of right recurrent nerve node: why does early metastasis of esophageal cancer occur in it? Surg Radiol Anat 2006;28:333-8. [PMID: 16718401 DOI: 10.1007/s00276-006-0115-y] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 2.3] [Reference Citation Analysis]
24 Bhat YM, Furth EE, Brensinger CM, Ginsberg GG. Endoscopic Resection with Ligation Using a Multi-Band Mucosectomy System in Barrett's Esophagus with High-Grade Dysplasia and Intramucosal Carcinoma. Therap Adv Gastroenterol 2009;2:323-30. [PMID: 21180580 DOI: 10.1177/1756283X09346794] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
25 Rice TW, Ishwaran H, Hofstetter WL, Schipper PH, Kesler KA, Law S, Lerut EM, Denlinger CE, Salo JA, Scott WJ, Watson TJ, Allen MS, Chen LQ, Rusch VW, Cerfolio RJ, Luketich JD, Duranceau A, Darling GE, Pera M, Apperson-Hansen C, Blackstone EH. Esophageal Cancer: Associations With (pN+) Lymph Node Metastases. Ann Surg. 2017;265:122-129. [PMID: 28009736 DOI: 10.1097/sla.0000000000001594] [Cited by in Crossref: 50] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
26 Yamashita H, Seto Y, Sano T, Makuuchi H, Ando N, Sasako M; Japanese Gastric Cancer Association and the Japan Esophageal Society. Results of a nation-wide retrospective study of lymphadenectomy for esophagogastric junction carcinoma. Gastric Cancer. 2017;20:69-83. [PMID: 27796514 DOI: 10.1007/s10120-016-0663-8] [Cited by in Crossref: 69] [Cited by in F6Publishing: 62] [Article Influence: 11.5] [Reference Citation Analysis]
27 Niclauss N, Chevallay M, Frossard JL, Mönig SP. [Surgical strategy for early stage carcinoma of the esophagus]. Chirurg 2018;89:339-46. [PMID: 29392342 DOI: 10.1007/s00104-018-0589-2] [Reference Citation Analysis]
28 Zhu H, Chen X, Chen B, Chen B, Song W, Sun D, Zhao Y. Activating transcription factor 4 promotes esophageal squamous cell carcinoma invasion and metastasis in mice and is associated with poor prognosis in human patients. PLoS One 2014;9:e103882. [PMID: 25078779 DOI: 10.1371/journal.pone.0103882] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
29 Qi X, Li M, Zhao S, Luo J, Shao Y, Zhang Z, Chen Y. Prevalence of metastasis in T1b esophageal squamous cell carcinoma: a retrospective analysis of 258 Chinese patients. J Thorac Dis 2016;8:966-76. [PMID: 27162673 DOI: 10.21037/jtd.2016.03.69] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
30 Law S, Wong J. Esophageal cancer. Curr Opin Gastroenterol 2000;16:386-91. [PMID: 17031106 DOI: 10.1097/00001574-200007000-00016] [Reference Citation Analysis]
31 Leggett CL, Lewis JT, Wu TT, Schleck CD, Zinsmeister AR, Dunagan KT, Lutzke LS, Wang KK, Iyer PG. Clinical and histologic determinants of mortality for patients with Barrett’s esophagus-related T1 esophageal adenocarcinoma. Clin Gastroenterol Hepatol. 2015;13:658-664.e1-3. [PMID: 25151255 DOI: 10.1016/j.cgh.2014.08.016] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
32 Ishwaran H, Blackstone EH, Apperson-Hansen C, Rice TW. A novel approach to cancer staging: application to esophageal cancer. Biostatistics 2009;10:603-20. [PMID: 19502615 DOI: 10.1093/biostatistics/kxp016] [Cited by in Crossref: 58] [Cited by in F6Publishing: 47] [Article Influence: 4.5] [Reference Citation Analysis]
33 Li H, Zheng D, Zhang B, Liu L, Ou J, Chen W, Xiong S, Gu Y, Yang J. Mir-208 promotes cell proliferation by repressing SOX6 expression in human esophageal squamous cell carcinoma. J Transl Med. 2014;12:196. [PMID: 25023649 DOI: 10.1186/1479-5876-12-196] [Cited by in Crossref: 56] [Cited by in F6Publishing: 53] [Article Influence: 7.0] [Reference Citation Analysis]
34 Krasna MJ. Stage-specific therapy for cancer of the oesophagus: a new 'cancer of the elderly'. Drugs Aging 2009;26:185-94. [PMID: 19358615 DOI: 10.2165/00002512-200926030-00001] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
35 Wani S, Abrams J, Edmundowicz SA, Gaddam S, Hovis CE, Green D, Gupta N, Higbee A, Bansal A, Rastogi A, Early D, Lightdale CJ, Sharma P. Endoscopic mucosal resection results in change of histologic diagnosis in Barrett's esophagus patients with visible and flat neoplasia: a multicenter cohort study. Dig Dis Sci 2013;58:1703-9. [PMID: 23633158 DOI: 10.1007/s10620-013-2689-7] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 5.8] [Reference Citation Analysis]
36 Prasad GA, Buttar NS, Wongkeesong LM, Lewis JT, Sanderson SO, Lutzke LS, Borkenhagen LS, Wang KK. Significance of neoplastic involvement of margins obtained by endoscopic mucosal resection in Barrett’s esophagus. Am J Gastroenterol. 2007;102:2380-2386. [PMID: 17640326 DOI: 10.1111/j.1572-0241.2007.01419.x] [Cited by in Crossref: 70] [Cited by in F6Publishing: 49] [Article Influence: 4.7] [Reference Citation Analysis]
37 Nentwich MF, von Loga K, Reeh M, Uzunoglu FG, Marx A, Izbicki JR, Bogoevski D. Depth of submucosal tumor infiltration and its relevance in lymphatic metastasis formation for T1b squamous cell and adenocarcinomas of the esophagus. J Gastrointest Surg. 2014;18:242-249; discussion 249. [PMID: 24091912 DOI: 10.1007/s11605-013-2367-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
38 Konda VJ, Dalal K. Optimal management of Barrett's esophagus: pharmacologic, endoscopic, and surgical interventions. Ther Clin Risk Manag 2011;7:447-58. [PMID: 22162921 DOI: 10.2147/TCRM.S23425] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
39 Roedl JB, Sahani DV, Colen RR, Fischman AJ, Mueller PR, Blake MA. Tumour length measured on PET-CT predicts the most appropriate stage-dependent therapeutic approach in oesophageal cancer. Eur Radiol. 2008;18:2833-2840. [PMID: 18651155 DOI: 10.1007/s00330-008-1078-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
40 Watson TJ. Endoscopic therapies for Barrett's neoplasia. J Thorac Dis 2014;6 Suppl 3:S298-308. [PMID: 24876934 DOI: 10.3978/j.issn.2072-1439.2014.03.35] [Reference Citation Analysis]
41 Londono R, Jobe BA, Hoppo T, Badylak SF. Esophagus and regenerative medicine. World J Gastroenterol 2012; 18(47): 6894-6899 [PMID: 23322986 DOI: 10.3748/wjg.v18.i47.6894] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
42 Zhang P, Xi M, Zhao L, Li QQ, He L, Liu S, Shen J, Liu MZ. Unilateral cervical nodal metastasis is an independent prognostic factor for esophageal squamous cell carcinoma patients undergoing chemoradiotherapy: a retrospective study. PLoS One 2014;9:e101332. [PMID: 24979040 DOI: 10.1371/journal.pone.0101332] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
43 Hagen JA, DeMeester SR, Peters JH, Chandrasoma P, DeMeester TR. Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies. Ann Surg. 2001;234:520-530; discussion 530-531. [PMID: 11573045 DOI: 10.1097/00000658-200110000-00011] [Cited by in Crossref: 266] [Cited by in F6Publishing: 239] [Article Influence: 12.7] [Reference Citation Analysis]
44 Yoon HH, Khan M, Shi Q, Cassivi SD, Wu TT, Quevedo JF, Burch PA, Sinicrope FA, Diasio RB. The prognostic value of clinical and pathologic factors in esophageal adenocarcinoma: a mayo cohort of 796 patients with extended follow-up after surgical resection. Mayo Clin Proc. 2010;85:1080-1089. [PMID: 21123634 DOI: 10.4065/mcp.2010.0421] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
45 Foley KG, Fielding P, Lewis WG, Roberts SA. Additional value of EUS in oesophageal cancer patients staged N0 on PET/CT: validation of a prognostic model. Surg Endosc 2018;32:4973-9. [PMID: 29869086 DOI: 10.1007/s00464-018-6259-0] [Reference Citation Analysis]
46 Sappati Biyyani RS, Chak A. Barrett's esophagus: review of diagnosis and treatment. Gastroenterol Rep (Oxf) 2013;1:9-18. [PMID: 24759662 DOI: 10.1093/gastro/got015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
47 Kumarasinghe MP, Bourke MJ, Brown I, Draganov PV, McLeod D, Streutker C, Raftopoulos S, Ushiku T, Lauwers GY. Pathological assessment of endoscopic resections of the gastrointestinal tract: a comprehensive clinicopathologic review. Mod Pathol 2020;33:986-1006. [PMID: 31907377 DOI: 10.1038/s41379-019-0443-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
48 Li C, Yamashita DT, Hawel JD, Bethune D, Henteleff H, Ellsmere J. Endoscopic mucosal resection versus esophagectomy for intramucosal adenocarcinoma in the setting of barrett's esophagus. Surg Endosc 2017;31:4211-6. [PMID: 28342132 DOI: 10.1007/s00464-017-5479-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
49 Cho JW, Choi SC, Jang JY, Shin SK, Choi KD, Lee JH, Kim SG, Sung JK, Jeon SW, Choi IJ, Kim GH, Jee SR, Lee WS, Jung HY; Korean ESD Study Group. Lymph Node Metastases in Esophageal Carcinoma: An Endoscopist's View. Clin Endosc. 2014;47:523-529. [PMID: 25505718 DOI: 10.5946/ce.2014.47.6.523] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 6.6] [Reference Citation Analysis]
50 Wang Y, Xiao P, Yang N, Wang X, Ma K, Wu L, Zhang W, Zhuang X, Xie T, Fang Q, Lan M, Wang Q, Peng L. Unresected small lymph node assessment predicts prognosis for patients with pT3N0M0 thoracic esophageal squamous cell carcinoma. World J Surg Oncol 2021;19:303. [PMID: 34657600 DOI: 10.1186/s12957-021-02412-1] [Reference Citation Analysis]
51 Ji X, Cai J, Chen Y, Chen LQ. Lymphatic spreading and lymphadenectomy for esophageal carcinoma. World J Gastrointest Surg 2016; 8(1): 90-94 [PMID: 26843917 DOI: 10.4240/wjgs.v8.i1.90] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
52 Cho JW. The role of endoscopic ultrasonography in T staging: early gastric cancer and esophageal cancer. Clin Endosc. 2013;46:239-242. [PMID: 23767033 DOI: 10.5946/ce.2013.46.3.239] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
53 Alkhoury F, Martin JT, Fiedler P, Jaffe PE. Esophageal granular cell tumor colliding with intramucosal adenocarcinoma: a case report. Cases J. 2009;2:8093. [PMID: 19830048 DOI: 10.4076/1757-1626-2-8093] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
54 Li H, Chen TW, Li ZL, Zhang XM, Chen XL, Wang LY, Zhou L, Li R, Li CP, Huang XH. Tumour size of resectable oesophageal squamous cell carcinoma measured with multidetector computed tomography for predicting regional lymph node metastasis and N stage. Eur Radiol. 2012;22:2487-2493. [PMID: 22653286 DOI: 10.1007/s00330-012-2512-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
55 Koyanagi K, Kato F, Kanamori J, Daiko H, Ozawa S, Tachimori Y. Clinical significance of esophageal invasion length for the prediction of mediastinal lymph node metastasis in Siewert type II adenocarcinoma: A retrospective single-institution study. Ann Gastroenterol Surg 2018;2:187-96. [PMID: 29863189 DOI: 10.1002/ags3.12069] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
56 DeMeester SR. Evaluation and treatment of superficial esophageal cancer. J Gastrointest Surg. 2010;14 Suppl 1:S94-S100. [PMID: 19760303 DOI: 10.1007/s11605-009-1025-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
57 Zemler B, May A, Ell C, Stolte M. Early Barrett's carcinoma: the depth of infiltration of the tumour correlates with the degree of differentiation, the incidence of lymphatic vessel and venous invasion. Virchows Arch. 2010;456:609-614. [PMID: 20449614 DOI: 10.1007/s00428-010-0925-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
58 Siewert JR, Stein HJ, Feith M, Bruecher BL, Bartels H, Fink U. Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann Surg. 2001;234:360-7; discussion 368. [PMID: 11524589 DOI: 10.1097/00000658-200109000-00010] [Cited by in Crossref: 367] [Cited by in F6Publishing: 320] [Article Influence: 17.5] [Reference Citation Analysis]
59 Witteman BP, Foxwell TJ, Monsheimer S, Gelrud A, Eid GM, Nieponice A, O'Rourke RW, Hoppo T, Bouvy ND, Badylak SF, Jobe BA. Transoral endoscopic inner layer esophagectomy: management of high-grade dysplasia and superficial cancer with organ preservation. J Gastrointest Surg 2009;13:2104-12. [PMID: 19826883 DOI: 10.1007/s11605-009-1053-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
60 Kumble LD, Silver E, Oh A, Abrams JA, Sonett JR, Hur C. Treatment of early stage (T1) esophageal adenocarcinoma: Personalizing the best therapy choice. World J Meta-Anal 2019; 7(9): 406-417 [DOI: 10.13105/wjma.v7.i9.406] [Reference Citation Analysis]
61 Cheon YK, Kim WJ, Cho JY, Lee JS, Lee MS, Shim CS. Outcome of photodynamic therapy for early esophageal cancer. Gut Liver 2007;1:126-31. [PMID: 20485628 DOI: 10.5009/gnl.2007.1.2.126] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
62 Schölvinck D, Künzli H, Meijer S, Seldenrijk K, van Berge Henegouwen M, Bergman J, Weusten B. Management of patients with T1b esophageal adenocarcinoma: a retrospective cohort study on patient management and risk of metastatic disease. Surg Endosc. 2016;30:4102-4113. [PMID: 27357927 DOI: 10.1007/s00464-016-5071-y] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 6.2] [Reference Citation Analysis]
63 Benech N, O'Brien JM, Barret M, Jacques J, Rahmi G, Perrod G, Hervieu V, Jaouen A, Charissoux A, Guillaud O, Legros R, Walter T, Saurin JC, Rivory J, Prat F, Lépilliez V, Ponchon T, Pioche M. Endoscopic resection of Barrett's adenocarcinoma: Intramucosal and low-risk tumours are not associated with lymph node metastases. United European Gastroenterol J 2021;9:362-9. [PMID: 32903167 DOI: 10.1177/2050640620958903] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
64 Lerut T, Flamen P, Ectors N, Van Cutsem E, Peeters M, Hiele M, De Wever W, Coosemans W, Decker G, De Leyn P. Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: A prospective study based on primary surgery with extensive lymphadenectomy. Ann Surg. 2000;232:743-752. [PMID: 11088069 DOI: 10.1097/00000658-200012000-00003] [Cited by in Crossref: 196] [Cited by in F6Publishing: 156] [Article Influence: 8.9] [Reference Citation Analysis]
65 Luu C, Amaral M, Klapman J, Harris C, Almhanna K, Hoffe S, Frakes J, Pimiento JM, Fontaine JP. Endoscopic ultrasound staging for early esophageal cancer: Are we denying patients neoadjuvant chemo-radiation? World J Gastroenterol 2017; 23(46): 8193-8199 [PMID: 29290655 DOI: 10.3748/wjg.v23.i46.8193] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
66 Nasr JY, Schoen RE. Prevalence of adenocarcinoma at esophagectomy for Barrett's esophagus with high grade dysplasia. J Gastrointest Oncol 2011;2:34-8. [PMID: 22811825 DOI: 10.3978/j.issn.2078-6891.2010.027] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
67 Waxman I, Konda VJ. Mucosal ablation of Barrett esophagus. Nat Rev Gastroenterol Hepatol. 2009;6:393-401. [PMID: 19488071 DOI: 10.1038/nrgastro.2009.90] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
68 Nusrath S, Saxena AR, Raju KVVN, Patnaik S, Subramanyeshwar Rao T, Bollineni N. The Value of Lymphadenectomy Post-Neoadjuvant Therapy in Carcinoma Esophagus: a Review. Indian J Surg Oncol 2020;11:538-48. [PMID: 33013140 DOI: 10.1007/s13193-020-01156-w] [Reference Citation Analysis]
69 Konda VJ, Waxman I. Low risk of prevalent submucosal invasive cancer among patients undergoing esophagectomy for treatment of Barrett's esophagus with high grade dysplasia. J Gastrointest Oncol 2011;2:1-4. [PMID: 22811818 DOI: 10.3978/j.issn.2078-6891.2011.005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
70 Prasad GA, Buttar NS, Wongkeesong LM, Lewis JT, Sanderson SO, Lutzke LS, Borkenhagen LS, Wang KK. Significance of neoplastic involvement of margins obtained by endoscopic mucosal resection in Barrett's esophagus. Am J Gastroenterol. 2007;102:2380-2386. [PMID: 17640326 DOI: 10.1111/j.1572-0241.2007.01419] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
71 Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ; American Gastroenterological Association. American Gastroenterological Association technical review on the management of Barrett's esophagus. Gastroenterology. 2011;140:e18-52; quiz e13. [PMID: 21376939 DOI: 10.1053/j.gastro.2011.01.031] [Cited by in Crossref: 766] [Cited by in F6Publishing: 517] [Article Influence: 69.6] [Reference Citation Analysis]
72 Berry MF. Esophageal cancer: staging system and guidelines for staging and treatment. J Thorac Dis. 2014;6 Suppl 3:S289-S297. [PMID: 24876933 DOI: 10.3978/j.issn.2072-1439.2014.03.11] [Cited by in F6Publishing: 57] [Reference Citation Analysis]
73 Baretton GB, Aust DE. [Barrett's esophagus. An update]. Pathologe. 2012;33:5-16. [PMID: 22293785 DOI: 10.1007/s00292-011-1541-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
74 Dunbar KB, Spechler SJ. The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett's esophagus: a systematic review. Am J Gastroenterol. 2012;107:850-62; quiz 863. [PMID: 22488081 DOI: 10.1038/ajg.2012.78] [Cited by in Crossref: 150] [Cited by in F6Publishing: 122] [Article Influence: 15.0] [Reference Citation Analysis]
75 Wang Y, Zhu L, Xia W, Wang F. Anatomy of lymphatic drainage of the esophagus and lymph node metastasis of thoracic esophageal cancer. Cancer Manag Res. 2018;10:6295-6303. [PMID: 30568491 DOI: 10.2147/cmar.s182436] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
76 Badreddine RJ, Prasad GA, Lewis JT, Lutzke LS, Borkenhagen LS, Dunagan KT, Wang KK. Depth of submucosal invasion does not predict lymph node metastasis and survival of patients with esophageal carcinoma. Clin Gastroenterol Hepatol. 2010;8:248-253. [PMID: 19948247 DOI: 10.1016/j.cgh.2009.11.016] [Cited by in Crossref: 66] [Cited by in F6Publishing: 57] [Article Influence: 5.1] [Reference Citation Analysis]
77 Blackstone EH, Rice TW. From trees to wood and back: perspective on clinical data analysis in thoracic surgery. Thorac Surg Clin 2007;17:309-27, v. [PMID: 18072351 DOI: 10.1016/j.thorsurg.2007.07.005] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
78 Badylak SF, Hoppo T, Nieponice A, Gilbert TW, Davison JM, Jobe BA. Esophageal preservation in five male patients after endoscopic inner-layer circumferential resection in the setting of superficial cancer: a regenerative medicine approach with a biologic scaffold. Tissue Eng Part A. 2011;17:1643-1650. [PMID: 21306292 DOI: 10.1089/ten.tea.2010.0739] [Cited by in Crossref: 163] [Cited by in F6Publishing: 145] [Article Influence: 14.8] [Reference Citation Analysis]
79 Sgourakis G, Gockel I, Lyros O, Lanitis S, Dedemadi G, Polotzek U, Karaliotas C, Lang H. The Use of Neural Networks in Identifying Risk Factors for Lymph Node Metastasis and Recommending Management of T1b Esophageal Cancer. The American Surgeon 2012;78:195-206. [DOI: 10.1177/000313481207800238] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
80 Collard JM, Otte JB, Fiasse R, Laterre PF, De Kock M, Longueville J, Glineur D, Romagnoli R, Reynaert M, Kestens PJ. Skeletonizing en bloc esophagectomy for cancer. Ann Surg 2001;234:25-32. [PMID: 11420480 DOI: 10.1097/00000658-200107000-00005] [Cited by in Crossref: 76] [Cited by in F6Publishing: 63] [Article Influence: 3.6] [Reference Citation Analysis]
81 Veenendaal RA, Griffioen G, Lamers CB. Endoscopic treatment of Barrett's oesophagus. Scand J Gastroenterol Suppl 2004;:32-7. [PMID: 15696847 DOI: 10.1080/00855920410010979] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
82 Xing X, Zhang ZQ, Wen H, Li XJ. Potential risk factors for lymph node metastasis in esophageal cancer. Shijie Huaren Xiaohua Zazhi 2013; 21(16): 1544-1548 [DOI: 10.11569/wcjd.v21.i16.1544] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
83 Fernández-Sordo JO, Konda VJ, Chennat J, Madrigal-Hoyos E, Posner MC, Ferguson MK, Waxman I. Is Endoscopic Ultrasound (EUS) necessary in the pre-therapeutic assessment of Barrett's esophagus with early neoplasia? J Gastrointest Oncol 2012;3:314-21. [PMID: 23205307 DOI: 10.3978/j.issn.2078-6891.2012.038] [Cited by in F6Publishing: 9] [Reference Citation Analysis]